Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
53.05
+3.75 (7.61%)
May 7, 2026, 4:08 PM HKT

HKG:2315 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
996.281,585403.85417.66626.62466.45
Short-Term Investments
---7.899.15106.98
Trading Asset Securities
234.82--8.498.2-
Cash & Short-Term Investments
1,2311,585403.85434.04643.97573.42
Cash Growth
152.88%292.51%-6.96%-32.60%12.30%-40.11%
Accounts Receivable
306.16300.31229.61142.38107.68103.09
Other Receivables
16.617.586.936.044.1714.96
Receivables
322.76317.89236.54148.43111.85118.05
Inventory
180.31169.87110.489.923.7321.65
Other Current Assets
100.1875.8765.66130.69139.74161.11
Total Current Assets
1,8342,149816.53723.05919.3874.24
Property, Plant & Equipment
1,4821,2371,2131,4511,5991,391
Long-Term Investments
181.98192.06222.61241.24250.819.69
Other Intangible Assets
50.5852.761.1428.1330.656.06
Long-Term Deferred Tax Assets
0.970.990.96---
Long-Term Deferred Charges
105.3974.9296.35---
Other Long-Term Assets
21.8418.365.236.16-21.86
Total Assets
3,6773,7242,4152,4492,8002,303
Accounts Payable
98.91135.83115.48175.23146.19102.44
Accrued Expenses
28.0599.3438.0627.8951.6253.66
Short-Term Debt
67153.38181.04---
Current Portion of Long-Term Debt
297.2836.2217.58176.84126.67-
Current Portion of Leases
-31.9417.8626.3644.9426.9
Current Income Taxes Payable
8.3624.014.514.25.02
Current Unearned Revenue
115.1103.76102.1969.2256.3861.58
Other Current Liabilities
64.39367.8358.6997.56176.06196.96
Total Current Liabilities
679.09930.3534.91577.62606.05446.56
Long-Term Debt
276.54179.88156.13173.9152.17-
Long-Term Leases
352.89182.67197.67167.01191.5162.9
Long-Term Unearned Revenue
81.8282.5484.987.0789.9392.8
Long-Term Deferred Tax Liabilities
---1.9--
Other Long-Term Liabilities
-169.52603.1651.48709.36448.55
Total Liabilities
1,3901,5451,5771,6591,6491,051
Common Stock
446.9446.9399.4399.4399.4374.93
Additional Paid-In Capital
3,3483,3452,2181,9921,9921,516
Retained Earnings
-1,469-1,573-1,754-1,787-1,404-802.32
Treasury Stock
-44.12-45.35-32.76-27.18-18.99-
Comprehensive Income & Other
0.821.332.69209.09178.32159.03
Total Common Equity
2,2822,175834.06785.891,1461,247
Minority Interest
4.544.544.554.554.554.76
Shareholders' Equity
2,2862,179838.6790.441,1511,252
Total Liabilities & Equity
3,6773,7242,4152,4492,8002,303
Total Debt
993.71584.09570.28544.11415.2889.8
Net Cash (Debt)
237.41,001-166.43-110.07228.69483.62
Net Cash Growth
-----52.71%-44.82%
Net Cash Per Share
0.592.49-0.40-0.280.601.33
Filing Date Shares Outstanding
452.32446.9399.4399.4399.4396.69
Total Common Shares Outstanding
452.32446.9399.4399.4399.4374.93
Working Capital
1,1551,218281.62145.43313.25427.68
Book Value Per Share
5.044.872.091.972.873.33
Tangible Book Value
2,2312,122772.92757.761,1161,241
Tangible Book Value Per Share
4.934.751.941.902.793.31
Buildings
-1,0571,057---
Machinery
-506.04442.161,4371,2081,107
Construction In Progress
-34.091.735.19268.29181.96
Leasehold Improvements
---240.53161.75166.43
Source: S&P Global Market Intelligence. Standard template. Financial Sources.